XWELNasdaqServices-Personal ServicesFiscal year ends December 31
XWELL, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.72−0.02 (-2.38%)
Close on Oct 19, 2026
- Market cap
- $6.08M
- P/E (TTM)
- –
- Dividend yield
- –
XWELL, Inc. revenue by segment
By business segment
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XpresSpa | $4.17M | $4.20M | $4.65M | $4.82M | $4.89M | $4.29M | $4.56M | $4.85M | $4.92M | $4.44M | $4.39M | $4.96M | 58.4% | -14.6% |
| XpresTest | $2.47M | $1.92M | $1.89M | $2.03M | $2.16M | $2.18M | $2.43M | $3.14M | $3.84M | $3.64M | $2.37M | $2.32M | 34.6% | +14.6% |
| Naples Wax | $503.00K | $524.00K | $618.00K | $495.00K | $647.00K | $552.00K | $483.00K | $429.00K | $517.00K | $648.00K | – | – | 7.0% | -22.3% |
| Treat | – | – | – | – | – | – | $94.00K | $138.00K | $108.00K | $90.00K | – | $191.00K | – | – |
| Operating income | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XpresTest | $1.54M | $1.07M | $547.00K | $2.46M | $689.00K | $618.00K | $742.00K | $1.14M | $1.64M | $1.67M | $366.00K | -$5.27M | +122.9% |
| Naples Wax | $379.00K | $48.00K | -$4.79M | -$387.00K | -$240.00K | -$422.00K | -$319.00K | -$66.00K | -$30.00K | -$78.00K | – | – | -257.9% |
| XpresSpa | -$42.00K | -$592.00K | -$1.10M | -$318.00K | $579.00K | $800.00K | -$5.72M | -$2.36M | -$1.44M | -$2.78M | -$4.05M | -$2.95M | -107.3% |
| Corporate and other | -$3.98M | -$5.94M | -$3.70M | -$2.52M | -$3.72M | -$4.15M | -$2.37M | -$3.48M | -$2.06M | -$1.19M | -$1.66M | -$2.29M | +6.9% |
| Treat | – | – | – | – | – | – | -$24.00K | $81.00K | $631.00K | -$673.00K | $74.00K | -$1.59M | – |
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Services | $6.53M | $6.06M | $6.46M | $6.48M | $6.91M | $6.42M | $6.74M | $7.49M | $8.40M | $8.04M | $6.68M | $6.72M | 91.4% | -5.4% |
| Products | $614.00K | $574.00K | $693.00K | $863.00K | $784.00K | $603.00K | $731.00K | $936.00K | $880.00K | $691.00K | $722.00K | $747.00K | 8.6% | -21.7% |
| Other | – | – | – | – | – | – | – | – | – | – | $11.00K | $12.00K | – | – |
| Patient services revenue | – | – | – | – | – | – | – | – | – | – | $102.00K | $0 | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $5.94M | $5.36M | $5.07M | $6.45M | $6.20M | $5.71M | $5.28M | $7.42M | $7.77M | $7.35M | – | – | 83.1% | -4.2% |
| All other countries | $1.21M | $1.28M | $2.08M | $897.00K | $1.49M | $1.32M | $2.18M | $1.01M | $1.52M | $1.38M | – | – | 16.9% | -19.0% |
From the segment and revenue-disaggregation notes of Xwell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.